143 related articles for article (PubMed ID: 7488437)
21. Oral ondansetron for preventing nausea and vomiting.
Cooke CE; Mehra IV
Am J Hosp Pharm; 1994 Mar; 51(6):762-71. PubMed ID: 8010314
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer.
Lachaine J; Laurier C; Langleben A; Vaillant L
Crit Rev Oncol Hematol; 1999 Nov; 32(2):105-12. PubMed ID: 10612010
[No Abstract] [Full Text] [Related]
23. [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J; Szántó J
Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
[TBL] [Abstract][Full Text] [Related]
24. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region.
Rapoport BL
Curr Med Res Opin; 2014 Sep; 30(9):1875-81. PubMed ID: 24911369
[TBL] [Abstract][Full Text] [Related]
26. [Anti-emetic effect of ondansetron in cisplatin induced nausea and vomiting--a randomized clinical trial].
Zeng WY
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):273-5. PubMed ID: 1396075
[TBL] [Abstract][Full Text] [Related]
27. Is oral ondansetron really efficacious in the control of cisplatin-induced delayed emesis?
Martin M
J Clin Oncol; 1996 Apr; 14(4):1401-2. PubMed ID: 8648398
[No Abstract] [Full Text] [Related]
28. Oral ondansetron and intravenous dexamethasone in the prevention of cisplatin-induced emesis. A phase II trial in women.
Franchi M; Donadello N; Zanaboni F; Tusei A; Scorbati E
Oncology; 1995; 52(6):509-12. PubMed ID: 7478441
[TBL] [Abstract][Full Text] [Related]
29. Always more "setrons": how many do we need?
Aapro MS
Support Care Cancer; 1997 Jan; 5(1):1-2. PubMed ID: 9010981
[No Abstract] [Full Text] [Related]
30. Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
Ettinger DS
Semin Oncol; 1995 Aug; 22(4 Suppl 10):6-18. PubMed ID: 7570053
[No Abstract] [Full Text] [Related]
31. Are granisetron and ondansetron equivalent in the clinic?
Dilly S
Eur J Cancer; 1992; 28A Suppl 1():S32-5. PubMed ID: 1320918
[TBL] [Abstract][Full Text] [Related]
32. An increased loading dose of ondansetron: a north european, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2.
Brock P; Brichard B; Rechnitzer C; Langeveld NE; Lanning M; Söderhäll S; Laurent C
Eur J Cancer; 1996 Sep; 32A(10):1744-8. PubMed ID: 8983284
[TBL] [Abstract][Full Text] [Related]
33. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
34. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
[TBL] [Abstract][Full Text] [Related]
35. An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
Martoni A; Angelelli B; Guaraldi M; Strocchi E; Pannuti F
Eur J Cancer; 1996 Jan; 32A(1):82-5. PubMed ID: 8695248
[TBL] [Abstract][Full Text] [Related]
36. Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting.
Bosnjak SM; Neskovic-Konstantinovic ZB; Jovanovic-Micic DJ; Mitrovic LB; Radulovic SS
J Chemother; 1996 Aug; 8(4):315-8. PubMed ID: 8873840
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and management of nausea and emesis.
Dicato M
Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
[No Abstract] [Full Text] [Related]
38. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
39. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy.
Stewart DJ; Dahrouge S; Coyle D; Evans WK
J Clin Oncol; 1999 Jan; 17(1):344-51. PubMed ID: 10458253
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a single 8-mg i.v. dose of ondansetron hydrochloride for preventing chemotherapy-induced emesis.
Bernstein BJ; Ong C
Am J Health Syst Pharm; 2002 Apr; 59(7):650-2. PubMed ID: 11944605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
